MS
XGN icon

Maven Securities’s Exagen XGN Stock Holding History

Maven Securities’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-52,491
Closed -$610K – 1134
2021
Q4 		$610K Sell
52,491
-100,014
-66% -$1.17M 0.02% 495
2021
Q3 		$2.07M Sell
152,505
-11,408
-7% -$152K 0.07% 234
2021
Q2 		$2.47M Sell
163,913
-11,087
-6% -$170K 0.1% 181
2021
Q1 		$3.04M Buy
+175,000
New +$3.12M 0.14% 139

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Maven Securities's XGN Position: Q1 2022 in Review

Maven Securities sold out of Exagen (XGN) in Q1 2022, closing a stake of 52,491 shares — an estimated $610K sold.

Maven Securities first reported a position in XGN in Q1 2021 and held it in 4 quarters. The position peaked at $3.04M in Q1 2021. 53 funds tracked by Wall St. Rank hold XGN as of Q1 2022.

  • Maven Securities reported no remaining Exagen position as of Q1 2022 after selling out during the quarter.
  • Maven Securities sold 52,491 Exagen shares in Q1 2022, an estimated $610K.
  • Maven Securities first reported a position in Exagen in Q1 2021 and held it in 4 quarters.
  • Maven Securities's Exagen position peaked at $3.04M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q1 2022.

Based on Maven Securities's 13F filing for Q1 2022, filed 16 May 2022.